Treatment of upper limb dystonia with botulinum toxin

Journal of Clinical Neuroscience

Volumn 3, Issue 2, 1996, Pages 124-128

  Hayes, M W ^b   Yiannikas, C ^a,b  

^a Department of Microbiology and Infectious Diseases   (Australia)

^b WESTMEAD HOSPITAL   (Australia)

Author keywords

Botulinum toxin; Limb dystonia; Movement disorder

Indexed keywords

EID: 0008003765     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0967-5868(96)90004-1     Document Type: Article

References (25)

1. Karp BI, Hallett M. Therapy with botulinum toxin. Jankovic J, Hallett M. eds New York: Marcel Dekker, 1994: 305.
2. Coffield JA, Considine RV, Simpson LL. Therapy with botulinum toxin. Jankovic J, Hallett M. eds New York: Marcel Dekker, 1994: 2.
3. Sheehy MP, Marsden CD. Writer's cramp - a focal dystonia. Brain 1982; 105: 461-480.
4. Jedynak CP, Bonnet AM, Agid Y Tremor and idiopathic dystonia. Mov Disord 1991; 6 230-236.
5. Nutt JG, Muenter MD, Aronson A, Kurland LT, Melton LJ. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord 1988; 3: 188-194.
6. Waddy HM, Fletcher NA, Harding AE, Marsden CD. A genetic study of idiopathic focal dystonias. Ann Neurol 1991; 29: 320-324.
7. Nakashima K, Rothwell JC, Day BL, Thompson PD, Shannon K, Marsden CD. Reciprocal inhibition between forearm muscles in patients with writer's cramp and other occupational cramps, symptomatic hemidystonia and hemiparesis due to stroke. Brain 1989; 112: 681-697.
8. Reilly, JA, Hallett M, Cohen LG, Tarkka IM, Dang N. The N30 component of somatosensory evoked potentials in patients with dystonia. Electroenceph Clin Neurophysiol 1992; 84: 243-247.
9. Cohen LG, Brasil-Neto JP, Cammarota A et al. Intracortical excitability of motor cortex in patients with focal limb dystonia. Neurology 1993; 43: A421, 1009S.
10. Deuschl G, Toro C, Matsumoto J, Hallett M. The movement-related potential is abnormal in patients with writer's cramp. Mov Disord 1992; 7 (Supp 1); P374, 127.
11. Ceballos-Baumann AO, Sheean G, Passingham RE, Marsden CD, Brooks DJ. Motor reorganisation after botulinum toxin treatment for writer's cramp: a PET study. Mov Disord 1995; 10: P64,389.
12. Huttner WB. Snappy exocytotoxins. Nature 1993; 365: 104-105.
13. Hallett M, Glocker FX, Deuschl G. Mechanism of action of botulinum toxin. Ann Neurol 1994; 36:449.
14. Cohen LG, Hallett M, Geller BD, Hochberg F. Treatment of focal dystonias of the hand with botulinum toxin injections. J Neurol Neurosurg Psychiatry 1989; 52: 355-363.
15. Rivest J, Lees AJ, Marsden CD. Writer's cramp: treatment with botulinum toxin injections. Mov Disord 1991; 6: 55-59.
16. Poungvarin N. Writer's cramp: the experience with botulinum toxin injections in 25 patients. J Med Assoc Thai 1991; 74: 239-247.
17. Jankovi cJ, Schwartz K, Donovan D. Botulinum toxin treatment of cranio-cervical dystonia, spasmodic dysphonia, other focal dystonias and hemi-facial spasm. J Neurol Neurosurg Psychiatry 1990; 53: 633-639.
18. Pullman SL. The use of botulinum toxin in the treatment of focal dystonia. Columbia University College of Physicians and Surgeons Symposium: Department of Neurology, 1990; 77-88.
19. Yoshimura DM, Aminoff MJ, Olney RK. Botulinum toxin therapy for limb dystonias. Neurology 1992; 42: 627-630.
20. Tsui JKC, Bhatt M, Calne S, Calne DB. Botulinum toxin in the treatment of writer's cramp: a double-blind study. Neurology 1993; 43: 183-185.
21. Fahn S. Therapy with botulinum toxin. Jancovic J, Hallett M. eds New York: Marcel Dekker, 1994: 173-189
22. Pullman S. Therapy with botulinum toxin. Jancovic J, Hallett M. eds New York: Marcel Dekker, 1994: 307-321.
23. Cohen LG, Hallett M. Hand cramps: clinical features and electromyographic patterns in a focal dystonia. Neurology 1988; 38: 1005-1012.
24. Karp BI, Cole RA, Cohen LG, Grill S, Lou JS, Hallett M. Long-term botulinum toxin treatment of focal hand dystonia. Neurology 1994; 44: 70-76.
25. Newmark J, Hochberg FH. Isolated painless manual incoordination in 57 musicians. J Neurol Neurosurg Psychiatry 1987; 50: 291-295.